Neutrophil Gelatinase-associated Lipocalin (NGAL)
by Maccura Biotechnology Co., Ltd. 6 variants
Ref ECH0501061
Active
CE IVDD
Valid until
Not listed
FDA recalls
Not applicable
Documents
None, self-declared
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD | NumberB-ECH05010616B D-ECH05010616B | Date22 May 2022 | StatusActive |
Certificates
No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
European Union — CE/IVDD Active
Specification
- Device Name
- Neutrophil Gelatinase-associated Lipocalin (NGAL)
- Model / Reference
- ECH0501061
- Primary DI / UDI-DI
- D-ECH05010616B
- Basic UDI-DI
- B-ECH05010616B
- EMDN Code
- W0102060207 Neutrophil gelatinase associated lipocalin (lipocalin 2)
- Device Class
- Class IVD General
- EU market of registration
- Germany
Manufacturer details
- EUDAMED SRN
- CN-MF-000014618
- Authorised representative
- Shanghai International Holding Corp. GmbH(Europe) DE-AR-000000001
Other devices from Maccura Biotechnology Co., Ltd.
Properties
Other properties (6)
- Sterile: No
- Human Tissues: No
- Self Testing: No
- Near-Patient Testing: No
- Companion Diagnostics: No
- Surgical Instrument: No